3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Surgical Wound Infection
1
Pancreatic Neoplasms
1
Cystectomy
1
Interventions
Dexamethasone
56
Metformin
50
Cyclophosphamide
47
Saline Solution
39
Cytarabine
37
Cisplatin
37
Zoledronic Acid
34
Letrozole
34
Sodium Chloride
33
Carboplatin
33
Bupivacaine
31
Bevacizumab
31
Docetaxel
30
Vincristine
29
Methotrexate
29
Fluorouracil
28
Propofol
27
Capecitabine
27
Fentanyl
26
Doxorubicin
26
Rituximab
25
Drug Therapy
25
Dexmedetomidine
25
Prednisone
23
Paclitaxel
23
Gemcitabine
22
Oxaliplatin
21
Morphine
21
Radiotherapy
19
Prednisolone
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Interventional
×
Cefuroxime
×
Clear all
NCT06709196
2025-01-09
REINFORCE
Rigshospitalet, Denmark
Phase 4
Recruiting
248 enrolled
NCT05784311
2024-10-21
SPARROW
Leiden University Medical Center
Phase 4
Recruiting
344 enrolled